Dialysate Bicarbonate Reduction for CO2 Removal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for removing carbon dioxide in critically ill patients, such as those with acute respiratory distress syndrome, face challenges due to the development of metabolic acidosis when using Continuous Renal Replacement Therapy (CRRT), and existing technologies like Extracorporeal Carbon Dioxide Removal (ECCOR) are underutilized due to complexity and limited availability.

Innovation Solution

A method involving the use of a dialysate with a bicarbonate concentration lower than that in blood plasma, flowing through a semi-permeable membrane to reduce CO2 levels without causing metabolic acidosis, allowing for the reduction of carbon dioxide in blood plasma while maintaining stable blood pH, and potentially incorporating carbonic anhydrase for enhanced CO2 removal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If CRRT is used to remove CO2/bicarbonate from blood plasma, then CO2 levels are reduced, but metabolic acidosis develops due to pH instability

Engineering Contradiction:
ImproveCO2 concentration in blood plasmaVSAvoidblood plasma pH stability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention changes the bicarbonate concentration parameter in the dialysate from conventional levels (35-45 mmol/L) to a reduced level (0-20 mmol/L). This parameter change creates a favorable concentration gradient that enhances CO2 removal while the dialysate composition is simultaneously adjusted (increasing strong ion difference through chloride reduction or sodium increase) to maintain blood plasma pH stability and prevent metabolic acidosis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention implements a feedback mechanism by continuously monitoring blood plasma pH levels during CO2 removal and adjusting the dialysate composition accordingly. The strong ion difference in the dialysate is optimized based on real-time pH measurements to ensure that CO2 removal does not lead to harmful pH drops, thereby maintaining physiological balance

Inventive Principle:
Principle #23Feedback

2Quantity of substance

If ECCOR is used for CO2 removal, then CO2 levels are reduced, but the technology is underutilized due to complexity and limited availability

Engineering Contradiction:
ImproveCO2 concentration in blood plasmaVSAvoidsystem complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention makes CO2 removal technology universal by adapting it to use standard hemodialysis machines and dialyzers that are already widely available in hospitals worldwide. By utilizing existing infrastructure rather than requiring specialized ECCOR equipment, the technology becomes universally accessible through facilities already capable of providing dialysis

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention enables self-service CO2 removal by using the patient's own blood plasma and a simplified dialysate formulation. The system leverages the natural concentration gradient between blood plasma bicarbonate and reduced-bicarbonate dialysate to drive CO2 removal without requiring complex artificial lungs or oxygenators, allowing the process to proceed with minimal additional equipment

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If low volume lung protective ventilation is applied, then lung injury is reduced, but hypercapnia develops preventing successful application

Engineering Contradiction:
Improveventilator-induced lung injuryVSAvoidplasma CO2 levels
Core Design Contradiction:
Object-affected harmful factorsVSQuantity of substance

Solution Approach 1:

The invention extracts CO2 removal function from the respiratory system and transfers it to the renal replacement therapy system. By using dialysis to directly remove CO2 from blood plasma, the need for high ventilatory volumes is eliminated, allowing lung protective ventilation to be successfully applied without the compromising effect of hypercapnia

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively reduces CO2 levels in blood plasma, preventing metabolic acidosis and making CO2 removal more accessible and less invasive, potentially available in any facility capable of providing dialysis, while maintaining stable blood pH.

Implementation Method 1

flowing the blood plasma on one side of at least one semi-permeable membrane and flowing a dialysate on the other side of the at least one semi-permeable membrane

Methodology Applied
Scientific EffectDialysis: Semipermeable Membrane

Implementation Method 2

The dialysate has a concentration of bicarbonate less than the concentration of bicarbonate in the blood plasma before treating the blood plasma

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS10322221B2Removal of carbon dioxide via dialysis
Publication Date: 2019.06.18 UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
  • US10322221B2 patent drawing
  • US10322221B2 patent drawing
  • US10322221B2 patent drawing

AI summary

A method of reducing the concentration of carbon dioxide in blood plasma includes removing blood from a patient and treating or processing at least blood plasma of the blood by flowing the blood plasma on one side of at least one semi-permeable membrane and flowing a dialysate on the other side of the at least one semi-permeable membrane. The dialysate has a concentration of bicarbonate less than the concentration of bicarbonate in the blood plasma before treating the blood plasma and has a composition such that the blood plasma strong ion difference that results from treating the blood plasma in conjunction with an achieved reduction in blood plasma CO2 concentration results in a blood plasma pH that does not change by more than +/−0.5 during treatment.